Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Broad protein cysteine residues and cellular redox systems represent a complex network of reactive thiol groups and biochemical pathways responsible for maintaining cellular homeostasis and mediating responses to oxidative stress. Cysteine residues are uniquely reactive due to their nucleophilic sulfur atoms, allowing them to serve as critical molecular switches through reversible post-translational modifications such as S-nitrosylation, S-glutathionylation, and disulfide bond formation (Marino & Gladyshev, 2012, Journal of Biological Chemistry). These modifications regulate a wide array of processes, including enzyme activity, protein-protein interactions, and signal transduction pathways like the Nrf2-Keap1 system (Finkel, 2011, Nature). The cellular redox environment is primarily maintained by the glutathione (GSH) and thioredoxin (Trx) systems, which provide the reducing equivalents necessary to prevent permanent oxidative damage. Therapeutic intervention in these systems often involves the use of electrophilic small molecules, such as Dimethyl fumarate or Bardoxolone methyl, which covalently modify specific 'druggable' cysteines to activate protective antioxidant genes (Linker et al., 2011, Brain). Other agents, like N-acetylcysteine, act by replenishing the cellular pool of glutathione to bolster antioxidant defenses. However, because reactive cysteines are ubiquitous throughout the proteome, achieving high selectivity for a single protein target is a major challenge. This lack of specificity can lead to broad systemic effects and potential off-target toxicity, making the 'broad' targeting of cysteine residues a complex pharmacological strategy that requires careful calibration to avoid disrupting essential redox-dependent physiological functions (Go & Jones, 2013, Free Radical Biology and Medicine).
Covalent modification of cysteine thiol groups (S-alkylation/S-oxidation), modulation of the glutathione-ascorbate cycle, and activation of antioxidant response elements (ARE) via the Nrf2/Keap1 pathway.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Broad protein cysteine residues and cellular redox systems.